$MYO News
Last published 2d ago
- 2d agoMYOThird Quarter 2026 Financial Results - MYOMO INCEarnings Call TranscriptsGood day, and welcome to the MIOMO's 3rd Quarter 2026 Financial Results Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the sta
- 2d agoMYOMYOMO, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2d agoMYOMyomo Reports Third Quarter 2026 Financial and Operating ResultsBusiness WireBURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2026. “The focus on our four success pillars helped deliver record ...
- 2w agoKIDSOMDAENOVMYO+1PRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy MonthGlobeNewswireOrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE
- 1mo agoMYOINSPMyomo Appoints Mary-Katherine McClure as Chief Commercial OfficerBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 2mo agoMYOMyomo to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 3mo agoMYOSecond Quarter 2026 Financial Results - MYOMO INCEarnings Call TranscriptsGood day and welcome to the Myomo second quarter 2026 financial results conference call. All participants will be in listen only mode. Should you need assistance, please signal a conference specialist by pressing the sta
- 3mo agoMYOMyomo Reports Second Quarter 2026 Financial and Operating ResultsBusiness WireRevenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guidance to $45-47 million Conference call begins at 4:30pm
- 3mo agoMYOMyomo to Report Second Quarter 2026 Financial Results on August 5Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 4mo agoMYOMyomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment ConferenceBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 6mo agoMYOMyomo Announces Participation in Upcoming Investor ConferencesBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 6mo agoMYOMyomo Appoints Joseph M. Manko to its Board of DirectorsBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 6mo agoMYOMyomo Reports First Quarter 2026 Financial and Operating ResultsBusiness WireRevenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses
- 6mo agoMYOMyomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.Business WireMyomo, Inc. (NYSE:MYO), a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace, announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock
- 6mo agoMYOMyomo to Report First Quarter 2026 Financial Results on May 7Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 6mo agoMYOMyomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient EngagementBusiness WireMyomo, Inc. (NYSE:MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new
- 6mo agoMYOOPRXMyomo Appoints William J Febbo to its Board of DirectorsBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today
- 8mo agoMYOMyomo Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsBusiness WireFourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources Record 241 authorizations and orders in the quarter Introduces 2026 revenue
- 8mo agoMYOMyomo and Elevance Health Agree to Contract for Multi-State Network ParticipationBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has
- 8mo agoMYOMyomo to Report Fourth Quarter 2025 Financial Results on March 9Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo Reports Third Quarter 2025 Financial and Operating ResultsBusiness WireRevenue of $10.1 million 229 authorizations and orders, highest number this year Reiterates full year revenue guidance of $40 million to $42 million Conference call begins today at 4:30pm Eastern time Myomo, Inc.
- 1y agoMYOMyomo to Report Third Quarter 2025 Financial Results on November 10Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo, Inc. (MYO) Q2 2025 Earnings Conference Call TranscriptEarnings Call Transcripts
- 1y agoMYOMyomo Reports Second Quarter 2025 Financial and Operating ResultsBusiness WireRevenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable
- 1y agoMYOMyomo to Report Second Quarter 2025 Financial Results on August 11Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo Provides Highlights of Today's Investor & Analyst Day EventBusiness WireSenior executives to provide an in-depth review of the Company's business model and discuss long-range aspirational financial metrics Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics
- 1y agoMYOMyomo Reports First Quarter 2025 Financial and Operating ResultsBusiness WireRevenue of $9.8 million Record 700 patients added to the pipeline More than 300 Certified Prosthetists Orthotists have completed initial MyoPro® training Conference call being held today at 4:30pm Eastern
- 1y agoMYOMyomo to Host Investor & Analyst Day Event on June 18, 2025Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company
- 1y agoMYOMyomo to Report First Quarter 2025 Financial Results on May 7Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo Launches the MyoPro® 2xBusiness WireA Major Step Forward in Donning, Fit, and Function - Enhancing User Independence Myomo, Inc. (NYSE:MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb
- 1y agoMYOMyomo Announces Upcoming Changes to its Board of DirectorsBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo to Present at the 24th Annual Needham Virtual Healthcare ConferenceBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoMYOMyomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 MillionBusiness WireGenerated first-ever positive quarterly cash flow from operations Received a record 233 MyoPro® authorizations and orders with 657 additions to the pipeline Introduces 2025 revenue guidance of $50 million to $53
- 1y agoMYOMyomo to Report Fourth Quarter 2024 Financial Results on March 10Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 1y agoINGNMDTMYOInogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom WestBusiness Wire
- 1y agoMYOMyomo, Inc. Prices $15.0 Million Public Offering of Common StockBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has priced an
- 1y agoMYOMyomo, Inc. Announces Proposed Public Offering of Common StockBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it intends to
- 2y agoMYOMyomo, Inc. (MYO) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMYOMyomo Reports Record Third Quarter Financial and Operating ResultsBusiness Wire$9.2 million in revenue, raises full-year revenue guidance 225 MyoPro® authorizations and orders with 316 patients in backlog at quarter end 645 additions to the pipeline result in 1,263 patients in the pipeline as
- 2y agoMYOMyomo Announces First Private Payer Contracts for MyoPro In-network CoverageBusiness WireBlue Cross Blue Shield of Massachusetts and Paradigm together serve 3 million covered lives Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for
- 2y agoMYOMyomo to Report Third Quarter Financial Results on November 6, 2024Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 2y agoMYOMyomo to Participate in the 2024 Maxim Healthcare Virtual SummitBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 2y agoMYOMyomo, Inc. Announces the Launch of Myomo Academy at AOPA National AssemblyBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the
- 2y agoMYOMyomo to Participate in Two Investor Conferences in SeptemberBusiness WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 2y agoMYOMyomo, Inc. (MYO) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMYOMyomo Reports Second Quarter 2024 Financial ResultsBusiness WireRecord revenue of $7.5 million Record 213 MyoPro® authorizations and orders Record 550 additions to the pipeline, with 1,179 patients in the pipeline at quarter-end Myomo, Inc. (NYSE:MYO) ("Myomo" or the
- 2y agoMYOMyomo to Report Second Quarter Financial Results on August 6, 2024Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that
- 2y agoMYOMyomo Reports Preliminary Second Quarter 2024 Revenues and Operating MetricsBusiness WireExpects record quarterly revenues of $7.2 million to $7.4 million, an increase of 92% to 97% sequentially Generates record pipeline additions, and authorizations and orders Myomo, Inc. (NYSE:MYO) ("Myomo" or the
- 2y agoMYOMyomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024Business WireMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that